Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Antibiotic resistance explored in myeloma stem cell transplants

NCT ID NCT05824689

First seen Jun 08, 2026 · Last updated Jun 18, 2026 · Updated 2 times

Summary

This study aimed to find out how common antibiotic resistance is in multiple myeloma patients receiving a stem cell transplant. Researchers planned to collect data from 124 adults to help design future studies on preventing infections. The study was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • John Theurer Cancer Center, Hackensack Meridian Health

    Hackensack, New Jersey, 07601, United States

  • Lombardi Comprehensive Cancer Center, Georgetown University

    Washington D.C., District of Columbia, 20007, United States

Conditions

The condition(s) this trial relates to.

Febrile Neutropenia plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.